Načítá se...
Non-invasive screening for NAFLD and advanced fibrosis in diabetes in primary care setting by MRI and MRE
BACKGROUND: Current guidelines do not recommend screening for nonalcoholic fatty liver disease (NAFLD) or advanced fibrosis. Patients with type 2 diabetes mellitus (T2DM) are known to be at increased risk for NAFLD and advanced fibrosis. AIM: We aimed to assess the feasibility in diabetics in a prim...
Uloženo v:
| Vydáno v: | Aliment Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673036/ https://ncbi.nlm.nih.gov/pubmed/26369383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13405 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|